Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
FEBS Letters|November 11, 1999
Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cellsG Hong, L M Baudhuin, Y XuClinical Pharmacology and Therapeutics|September 14, 2007
Translation of pharmacogenetics into clinically relevant testing modalitiesL M Baudhuin, L J Langman, D J O'KaneJournal of the Society for Gynecologic Investigation|February 27, 2001
The role and clinical applications of bioactive lysolipids in ovarian cancerY Xu, Y J Xiao, L M Baudhuin, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|December 16, 2016
Effect of genetic variants of bilirubin metabolism on the degree of hyperbilirubinemia in African-American newbornsD L Schutzman, L M Baudhuin, E Gatien, et al.Nature Cell Biology|May 12, 2000
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1Y Xu, K Zhu, G Hong, et al.Gynecologic Oncology|May 2, 2001
Lysophospholipids increase interleukin-8 expression in ovarian cancer cellsB M Schwartz, G Hong, B H Morrison, et al.The Journal of Biological Chemistry|September 6, 2001
Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4K Zhu, L M Baudhuin, G Hong, et al.Genome Medicine|December 31, 2024
Interpretation and classification of FBN1 variants associated with Marfan syndrome: consensus recommendations from the Clinical Genome Resource's FBN1 variant curation expert panelA Drackley, C Somerville, P Arnaud, et al.Pageof 1